The estimated Net Worth of Shamim Ruff is at least $2 Million dollars as of 28 July 2023. Shamim Ruff owns over 8,235 units of Sarepta Therapeutics Inc stock worth over $2,002,114 and over the last 8 years Shamim sold SRPT stock worth over $0.
Shamim has made over 8 trades of the Sarepta Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Shamim exercised 8,235 units of SRPT stock worth $759,267 on 28 July 2023.
The largest trade Shamim's ever made was exercising 12,138 units of Sarepta Therapeutics Inc stock on 20 July 2017 worth over $168,840. On average, Shamim trades about 3,075 units every 132 days since 2016. As of 28 July 2023 Shamim still owns at least 15,594 units of Sarepta Therapeutics Inc stock.
You can see the complete history of Shamim Ruff stock trades at the bottom of the page.
Shamim's mailing address filed with the SEC is 5320 LEGACY DRIVE, , PLANO, TX, 75024.
Over the last 12 years, insiders at Sarepta Therapeutics Inc have traded over $58,674,663 worth of Sarepta Therapeutics Inc stock and bought 827,614 units worth $49,516,406 . The most active insiders traders include John C Martin, Richard Barry, and M Kathleen Behrens. On average, Sarepta Therapeutics Inc executives and independent directors trade stock every 37 days with the average trade being worth of $2,737,275. The most recent stock trade was executed by Ian Michael Estepan on 30 August 2024, trading 5,985 units of SRPT stock currently worth $822,100.
sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com.
Sarepta Therapeutics Inc executives and other stock owners filed with the SEC include: